Literature DB >> 331326

Immunohistochemical analysis of peptide pathways possibly related to pain and analgesia: enkephalin and substance P.

T Hökfelt, A Ljungdahl, L Terenius, R Elde, G Nilsson.   

Abstract

The distribution of Met-enkephalin- and substance P-immunoreactive neurons was studied by indirect immunofluorescence in some areas related to pain and analgesia. Met-enkephalin- and substance P-positive cell bodies and nerve terminals were observed in the periaqueductal central gray, the nucleus raphe magnus, the marginal layers and substantia gelatinosa of the spinal trigeminal nucleus, and the dorsal horn of the spinal cord. Lesion experiments suggest that Met-enkephalin neurons in the dorsal horn and possibly in the spinal trigeminal nucleus are interneurons or propriospinal neurons with nerve terminals in the laminae I and II of the cord and in the superficial layers of the spinal trigeminal nucleus, respectively. These areas are also very rich in substance P-positive nerve terminals, mainly representing central branches of primary afferent neurons. The present immunohistochemical-anatomical findings support the hypothesis that stimulation-produced analgesia is related to activation of spinal and spinal trigeminal enkephalin interneurons forming axo-axonic synapses with (substance P?) pain afferents in the superficial laminae of the dorsal horn and the spinal trigeminal nucleus. These interneurons may be activated by sensory fibers and by descending fibers from medullary stimulation sites. Transmitter substances in these descending fibers may be 5-hydroxytryptamine and substance P.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 331326      PMCID: PMC431417          DOI: 10.1073/pnas.74.7.3081

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  Fluorescent antibody methods.

Authors:  A H COONS
Journal:  Gen Cytochem Methods       Date:  1958

2.  Opiate and stimulus-produced analgesia: functional anatomy of a medullospinal pathway.

Authors:  A I Basbaum; C H Clanton; H L Fields
Journal:  Proc Natl Acad Sci U S A       Date:  1976-12       Impact factor: 11.205

3.  An unidentified depressor substance in certain tissue extracts.

Authors:  U S V Euler; J H Gaddum
Journal:  J Physiol       Date:  1931-06-06       Impact factor: 5.182

Review 4.  Central nervous system mechanisms of analgesia.

Authors:  David J Mayer; Donald D Price
Journal:  Pain       Date:  1976-12       Impact factor: 6.961

5.  Opioid peptide enkephalin: immunohistochemical mapping in rat central nervous system.

Authors:  R Simantov; M J Kuhar; G R Uhl; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

6.  Reversal of morphine and stimulus-produced analgesia by subtotal spinal cord lesions.

Authors:  Allan I Basbaum; Nicholas J E Marley; John O'Keefe; Charles H Clanton
Journal:  Pain       Date:  1977-02       Impact factor: 6.961

Review 7.  Neuroanatomical substrates of nociception in the spinal cord.

Authors:  F W Kerr
Journal:  Pain       Date:  1975-12       Impact factor: 6.961

8.  Electro-acupunture and endogenous morphines.

Authors:  B Sjölund; M Eriksson
Journal:  Lancet       Date:  1976-11-13       Impact factor: 79.321

9.  Analgesia induced by electrical stimulation of the inferior centralis nucleus of the raphe in the cat.

Authors:  J L Oliveras; F Redjemi; G Guilbaud; J M Besson
Journal:  Pain       Date:  1975-06       Impact factor: 6.961

10.  Naloxone reversal of analgesia produced by brain stimulation in the human.

Authors:  J E Adams
Journal:  Pain       Date:  1976-06       Impact factor: 6.961

View more
  80 in total

1.  Responsiveness of rat substantia gelatinosa neurones to mechanical but not thermal stimuli revealed by in vivo patch-clamp recording.

Authors:  H Furue; K Narikawa; E Kumamoto; M Yoshimura
Journal:  J Physiol       Date:  1999-12-01       Impact factor: 5.182

2.  Plasma pharmacokinetics and tissue and brain distribution of cisplatin in musk shrews.

Authors:  Julie L Eiseman; Jan H Beumer; Lora H Rigatti; Sandra Strychor; Kelly Meyers; Samuel Dienel; Charles C Horn
Journal:  Cancer Chemother Pharmacol       Date:  2014-11-15       Impact factor: 3.333

3.  Spinal neurons exhibiting a specific nociceptive response receive abundant substance P-containing synaptic contacts.

Authors:  Y De Koninck; A Ribeiro-da-Silva; J L Henry; A C Cuello
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

Review 4.  The enkephalins. Peptides with morphine-like activity.

Authors:  R J Miller; P Cuatrecasas
Journal:  Naturwissenschaften       Date:  1978-10

5.  Enkephalin inhibits release of substance P from sensory neurons in culture and decreases action potential duration.

Authors:  A W Mudge; S E Leeman; G D Fischbach
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

6.  Attenuation of the morphine withdrawal syndrome by inhibition of catabolism of endogenous enkephalins in the periaqueductal gray matter.

Authors:  R Maldonado; M C Fournié-Zaluski; B P Roques
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-04       Impact factor: 3.000

7.  Delta-opioid mediated inhibitions of acute and prolonged noxious-evoked responses in rat dorsal horn neurones.

Authors:  A F Sullivan; A H Dickenson; B P Roques
Journal:  Br J Pharmacol       Date:  1989-11       Impact factor: 8.739

8.  Alterations in nociception following adrenal medullary transplants into the rat periaqueductal gray.

Authors:  J Sagen; G D Pappas; M J Perlow
Journal:  Exp Brain Res       Date:  1987       Impact factor: 1.972

9.  Naloxone reversible reduction in brain monoamine synthesis following sciatic nerve stimulation.

Authors:  H Nissbrandt; T Yao; P Thorén; T H Svensson
Journal:  J Neural Transm       Date:  1982       Impact factor: 3.575

10.  Post-tetanic depression of spinal reflexes in the rabbit and the possible involvement of opioid peptides.

Authors:  D M Catley; R W Clarke; J E Pascoe
Journal:  J Physiol       Date:  1984-07       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.